ROYCE & ASSOCIATES LP - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 48 filers reported holding ACORDA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$9,0000.0%12,892
-28.7%
0.00%
Q3 2020$9,000
-30.8%
18,0790.0%0.00%
Q2 2020$13,000
-23.5%
18,0790.0%0.00%
Q1 2020$17,000
-67.3%
18,079
-29.0%
0.00%
Q4 2019$52,000
-28.8%
25,4770.0%0.00%
-100.0%
Q3 2019$73,000
-60.5%
25,477
+5.8%
0.00%
-50.0%
Q2 2019$185,000
+478.1%
24,075
+889.5%
0.00%
Q1 2019$32,000
+23.1%
2,433
+48.1%
0.00%
Q4 2018$26,000
-18.8%
1,643
+1.8%
0.00%
Q3 2018$32,000
+100.0%
1,614
+183.2%
0.00%
Q2 2018$16,000
+60.0%
570
+41.8%
0.00%
Q1 2018$10,0004020.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 1,044,783$34,770,0004.41%
1492 Capital Management LLC 101,582$3,381,0001.96%
Tekla Capital Management LLC 680,862$22,659,0000.90%
ARBOR CAPITAL MANAGEMENT LLC 186,495$6,207,0000.74%
HUSSMAN STRATEGIC ADVISORS, INC. 210,000$6,989,0000.73%
Pergamon Offshore Advisors, L.P. 18,711$623,0000.60%
Partner Investment Management, L.P. 11,594$386,0000.58%
Penn Capital Management Company, LLC 426,937$14,208,0000.56%
HighPoint Advisor Group LLC 10,609$360,0000.55%
EAGLE ASSET MANAGEMENT INC 2,461,980$81,934,0000.47%
View complete list of ACORDA THERAPEUTICS INC shareholders